Cholecystokinin (CCK) and the CCKA receptor gene polymorphism, and smoking behavior

Psychiatry Research

Volumn 133, Issue 2-3, 2005, Pages 123-128

  Takimoto, Takahiro ^a,b   Terayama, Hayato ^c   Waga, Chikako ^a   Okayama, Takashi ^a   Ikeda, Kazutaka ^b   Fukunishi, Isao ^b   Iwahashi, Kazuhiko ^a,b  

^a AZABU UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

CCK gene; CCKA receptor gene; Polymorphism; Smoking behavior

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; DOPAMINE; NICOTINE;

ALLELE; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DNA POLYMORPHISM; DOPAMINE RELEASE; DRUG DEPENDENCE; EXON; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE FREQUENCY; GENETIC RISK; GENETIC VARIABILITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; TOBACCO DEPENDENCE;

EID: 14644404262     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2003.06.004     Document Type: Article

References (41)

1. P. Asherson, R. Mant, N. Williams, A. Cardno, L. Jones, K. Murphy, D.A. Collier, S. Nanko, N. Craddock, S. Moriss, W. Muir, B. Blackwood, P. McGuffin, and M.J. Qwen A study on chromosome 4p markers and dopamine D5 receptor gene in schizophrenia and bipolar disorder Molecular Psychiatry 3 1998 310 315
2. D.H. Blackwood, L. He, S.W. Morris, A. McLean, C. Whitton, M. Thomson, M.T. Walker, K. Woodburn, C.M. Sharp, A.F. Wright, Y. Shibasaki, D.M. St. Clair, D.J. Porteous, and W.J. Muir A locus for bipolar affective disorder on chromosome 4p Nature Genetics 12 1996 427 430
3. T. Bowen, N. Norton, N.J. Jacobsen, C. Guy, J.K. Daniels, R.D. Sanders, A.G. Cardno, L.A. Jones, K.C. Murphy, P. McGuffin, N. Craddock, M.C. O'Donovan, and M.J. Owen Linked polymorphisms upstream of exon 1 and 2 of the human cholecystokinin gene are not associated with schizophrenia or bipolar disorder Molecular Psychiatry 3 1998 67 71
4. D. Carmelli, G.E. Swan, D. Robinette, and R. Fabsitz Genetic influence on smoking-a study of male twins New England Journal of Medicine 327 1992 829 833
5. D.E. Comings, S. Wu, N. Gonzalez, W.G. Iacono, M. MacGue, W.W. Peters, and J.P. MacMurray Cholecystokinin (CCK) gene as a possible risk factor for smoking: a replication in two independent samples Molecular Genetics and Metabolism 73 2001 349 353
6. K.M. Conrad, B.R. Flay, and D. Hill Why children start smoking cigarettes: predictors of onset British Journal of Addiction 87 1992 1711 1724
7. J.N. Crawley Cholecystokinin-dopamine interactions Trends in Pharmacological Sciences 6 1991 232 236
8. J.N. Crawley, and R.L. Corwin Biological actions of cholecystokinin Peptides 15 1994 731 755
9. A. de Weerth, J.R. Pisegna, K. Huppi, and S.A. Wank Molecular cloning, functional expression and chromosomal localization of the human cholecystokinin type A receptor Biochemical and Biophysical Research Communications 194 1993 811 818
10. S.M. Farmery, F. Owen, M. Poulter, and T.J. Crow Reduced high affinity cholecystokinin binding in hippocampus and frontal cortex of schizophrenia patients Life Science 36 1985 473 477
11. I.N. Ferrier, T.J. Crow, S.M. Farmery, G.W. Roberts, F. Owen, T.E. Adrian, and S.R. Bloom Reduced cholecystokinin levels in the limbic lobe in schizophrenia. A marker for pathology underlying the defect state? Annals of the New York Academy of Sciences 448 1985 495 506
12. J. Gelernter, H.R. Kranzler, S.L. Satel, and P.A. Rao Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia Neuropsychopharmacology 11 1994 195 200
13. A. Hamann, B. Busing, H. Munzberg, De.A. Weerth, A. Hinney, H. Mayer, W. Siegfried, J. Hebebrand, and H. Greten Missense variants in the human cholecystokinin type A receptor gene: no evidence for association with early-onset obesity Hormone and Metabolic Research 3 1999 287 288
14. T.F. Heatherton, L.T. Kozlowski, R.C. Frecker, and K.O. Fagerstrom The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire British Journal of Addiction 86 9 1991 1119 1127
15. J.E. Henningfield, K. Miyasato, and D.R. Jasinski Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine Journal of Pharmacology and Experimental Therapeutics 234 1985 1 12
16. 3H-MK-329 Journal of Neuroscience 10 1990 1070 1081
17. S. Kinze, T. Schoneberg, R. Meyer, H. Martin, and R. Kaufmann Pharmacological characterization of CCKB receptors in human brain: no evidence for receptor heterogeneity Neuroscience Letters 217 1996 45 49
18. G.F. Koob, and F.E. Bloom Cellular and molecular mechanisms of drug dependence Science 242 1988 715 723
19. C. Lerman, N.E. Caporaso, J. Audrain, D. Main, E.D. Bowman, B. Lockshin, N.R. Boyd, and P.G. Shields Evidence suggesting the role of specific genetic factors in cigarette smoking Health Psychology 18 1999 14 20
20. C. Lerman, N.E. Caparaso, J. Audrain, D. Main, N.R. Boyd, and P.G. Shields Interacting effect of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence Molecular Psychiatry 5 2000 182 189
21. F.H. Marshall, S. Barnes, J. Hughes, G.N. Woodruff, and J.C. Hunter Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms Journal of Neurochemistry 56 1991 917 922
22. T.H. Moran, and G.L. Schwartz Neurobiology of cholecystokinin Critical Reviews in Neurobiology 9 1994 1 28
23. T.H. Moran, P. Robinson, M.S. Goldrich, and P.R. McHugh Two brain cholecystokinin receptors: implications for behavioral actions Brain Research 362 1986 175 179
24. T. Niu, C. Chen, J. Ni, B. Wang, Z. Fang, H. Shao, and X. Xu Nicotine dependence and its familial aggregation in Chinese International Journal of Epidemiology 29 2000 248 252
25. T. Okubo, and S. Harada Polymorphism of the CCK, CCKAR and CCKBR genes: an association with alcoholism study Journal of Study on Alcohol 62 2001 413 421
26. J. Palca Nicotine addiction Nature 333 1988 287
27. F.E. Pontieri, G. Tanda, F. Orzi, and G. Di Chiara Effects of nicotine on the nucleus accumbens and similarity to those of addictive drug Nature 382 1996 255 257
28. K. Rasmusssen, J.F. Czachura, M.J. Kallman, and D.R. Helton The CCK-B antagonist LY288513 blocks the effects of nicotine withdrawal on auditory startle NeuroReport 10 1996 1050 1052
29. J.F. Rehfeld Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog Journal of Biological Chemistry 253 1978 4022 4030
30. M.A. Russell, and C. Feyerabend Cigarette smoking: a dependence on high-nicotine boli Drug Metabolism Reviews 1978 29 57
31. S.Z. Sabol, M.L. Nelson, C. Fisher, L. Gunzerath, C.L. Brody, S. Hu, L.A. Sirota, S.E. Marcus, B.D. Greenberg, F.R.T. Lucas, J. Benjamin, D.L. Murphy, and D.H. Hamer A genetic association for cigarette smoking behavior Health Psychology 18 1999 7 13
32. P.F. Sullivan, and K.S. Kendler The genetic epidemiology of smoking Nicotine and Tobacco Research 1 Suppl. 2 1999 549 555
33. H. Tachikawa, S. Harada, Y. Kawanishi, T. Okubo, and H. Shiraishi Novel polymorphisms of the human cholecystokinin A receptor gene: an association analysis with schizophrenia American Journal of Medical Genetics 96 2000 141 145
34. F.J. Vaccarcino Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors Neuroscience and Biobehavioral Reviews 18 1994 207 214
35. D.J. Vandenbergh, A.M. Persico, A.L. Hawkins, C.A. Griffin, X. Li, E.W. Jabs, and G.R. Uhl Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR Genomics 14 1992 1104 1106
36. Z. Wang, J. Vanldes, R. Noyes, T. Zoega, and R.R. Crowe Possible association of cholecystokinin promoter polymorphism (CCK-36CT) with panic disorder American Journal of Medical Genetics 81 1998 228 234
37. S.A. Wank Cholecystokinin receptors American Journal of Physiology 269 1995 G628 G646
38. S.A. Wank, R. Harkins, R.T. Jensen, H. Shapira, A. de Weerth, and T. Slattery Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas Proceedings of the National Academy of Sciences of the United States of America 89 1992 3125 3129
39. S.A. Wank, J.R. Pisegna, and A. de Weerth Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression Proceeding of the National Academy of Sciences of the United States of America 89 1992 8691 8695
40. J. Wei, and G.P. Hemmings The CCK-A receptor gene possibly associated with auditory hallucinations in schizophrenia European Psychiatry 14 1999 67 70
41. X.Y. Zhang, D.F. Zhou, P.Y. Zhang, and J. Wei The CCK-A receptor gene possibly associated with positive symptoms of schizophrenia Molecular Psychiatry 5 2000 239 240